Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 34 | 50 | +16 |
| Shares | 2.47M | 5.20M | +2.73M (+110.4%) |
| Value | $10.6M | $43.2M | +$32.6M (+307.8%) |
New holders (22)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 707,338 | $5.88M | 0.42% |
| Velan Capital Investment Management LP | 471,559 | $3.92M | 2.28% |
| Stonepine Capital Management, LLC | 353,669 | $2.94M | 2.32% |
| Kalehua Capital Management LLC | 235,779 | $1.96M | 1.94% |
| DAFNA Capital Management LLC | 173,451 | $1.44M | 0.33% |
| Two Sigma Investments, LP | 118,218 | $982.4K | 0.00% |
| Jane Street Group, LLC | 101,722 | $845.3K | 0.00% |
| Marshall Wace, LLP | 85,173 | $707.8K | 0.00% |
| Two Sigma Advisers, LP | 44,430 | $369.2K | 0.00% |
| Squarepoint Ops LLC | 33,270 | $276.5K | 0.00% |
| Omers Administration Corp | 22,600 | $187.8K | 0.00% |
| Goldman Sachs Group Inc | 18,621 | $154.7K | 0.00% |
| HRT Financial LP | 17,356 | $144.0K | 0.00% |
| Legacy Trust | 17,234 | $143.2K | 0.03% |
| Walleye Capital LLC | 15,240 | $126.6K | 0.00% |
| XTX Topco Ltd | 14,662 | $121.8K | 0.00% |
| Beck Mack & Oliver LLC | 12,000 | $99.7K | 0.00% |
| Quadrature Capital Ltd | 11,954 | $99.3K | 0.00% |
| Man Group plc | 11,287 | $93.8K | 0.00% |
| Fortitude Family Office, LLC | 608 | $5.05K | 0.00% |
| International Assets Investment Management, LLC | 175 | $1.45K | 0.00% |
| JPMorgan Chase & Co | 47 | $391 | 0.00% |
Sold out (6)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| FMR LLC | 3,337 | $14.4K |
| Citigroup Inc | 2,065 | $8.90K |
| Nisa Investment Advisors, LLC | 142 | $612 |
| Advisor Group Holdings, Inc. | 568 | $301 |
| SRS Capital Advisors, Inc. | 9 | $38 |
| CWM, LLC | 56 | $0 |